Brief: Enliven Therapeutics Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants
11/06/2026 23:14
BRIEF-Enliven Therapeutics Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants June 11 (Reuters) - Enliven Therapeutics Inc ELVN.O:
ENLIVEN THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS
ENLIVEN THERAPEUTICS - COMMENCES $250 MILLION PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS
Source text: ID:nPnbZG5Y9a
Further company coverage: ELVN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enliven Therapeutics
See all newsBrief: Enliven Therapeutics Appoints Kristine Ball To Board Of Directors Ahead Of Planned Phase 3 Trial Initiation This Year
US RESEARCH ROUNDUP-Amrize, Dexcom, Lennar
U.S. RESEARCH ROUNDUP- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies
U.S. RESEARCH ROUNDUP-Caterpillar, Eli Lilly, McKesson
Enliven Therapeutics Q2 net loss widens on higher expenses